High Glucose Contributes to the Proliferation and Migration of Non-small Cell Lung Cancer Cells Via GAS5-TRIB3 Axis
Overview
Authors
Affiliations
Despite the growing number of studies exhibited an association of diabetes mellitus (DM) and lung cancer progression, the concrete mechanism of DM aggravating lung cancer has not been elucidated. This study was to investigate whether and how high glucose (HG) contribute to the proliferation and migration of non-small cell lung cancer (NSCLC) cells in vitro. In the present study, we confirmed that HG promoted the proliferation and migration of NSCLC cells, and also induced an anti-apoptosis effect on NSCLC cells. Moreover, HG inhibited the expression of GAS5 in NSCLC cells but elevated the protein level of TRIB3. GAS5 overexpression promoted the degradation of TRIB3 protein by ubiquitination and inhibited the HG induced-proliferation, anti-apoptosis and migration of NSCLC cells. Importantly, TRIB3 overexpression reversed the effects of GAS5 on the HG-treated NSCLC cells. Taken together, down-regulated GAS5 by HG significantly enhanced the proliferation, anti-apoptosis and migration in NSCLC cells through TRIB3, thus promoting the carcinogenesis of NSCLC.
LncRNA FAM138B inhibits the progression of non-small cell lung cancer through miR-105-5p.
Gao J, Pan T, Wang H, Wang S, Chai J, Jin C Cell Cycle. 2022; 22(7):808-817.
PMID: 36529892 PMC: 10026877. DOI: 10.1080/15384101.2022.2154556.
Raguraman R, Srivastava A, Munshi A, Ramesh R Adv Drug Deliv Rev. 2021; 178:113918.
PMID: 34375681 PMC: 8556346. DOI: 10.1016/j.addr.2021.113918.
TRIB3 Promotes Lung Adenocarcinoma Progression via an Enhanced Warburg Effect.
Xing Y, Luo P, Hu R, Wang D, Zhou G, Jiang J Cancer Manag Res. 2020; 12:13195-13206.
PMID: 33380827 PMC: 7767749. DOI: 10.2147/CMAR.S287956.
Inhibition of SNCG suppresses the proliferation of lung cancer cells induced by high glucose.
Fei J, Xiao C, Yang M, Zhou X, Gong P Mol Med Rep. 2020; 23(2).
PMID: 33313952 PMC: 7751455. DOI: 10.3892/mmr.2020.11777.
Yang Q, Han Y, Liu P, Huang Y, Li X, Jia L Front Pharmacol. 2020; 11:701.
PMID: 32508644 PMC: 7251029. DOI: 10.3389/fphar.2020.00701.